Ketamine for Nerve Pain and Peripheral Neuropathy: What the Evidence Shows

Peripheral neuropathy is one of the most debilitating and undertreated pain conditions in medicine. The burning, stabbing, electric-shock sensations in your feet and hands. The numbness that makes you unsteady. The pain that wakes you at 2am and refuses to let you back to sleep. For the estimated 20 million Americans living with peripheral neuropathy, the message from traditional medicine is often the same: "We can try gabapentin. We can try duloxetine. We can try amitriptyline."

And for millions of patients, those medications simply don't work — or cause side effects that feel as disabling as the pain itself.

Ketamine, long used in anesthesia and emerging as a powerful tool in mental health, is gaining serious scientific attention for its ability to interrupt the central pain mechanisms that make neuropathy so treatment-resistant.

What Is Peripheral Neuropathy?

Peripheral neuropathy occurs when nerves outside the brain and spinal cord are damaged, sending faulty signals to the brain — pain where there shouldn't be, or numbness where sensation matters. The most common causes include:

• Diabetic neuropathy — affecting up to 50% of people with diabetes
• Chemotherapy-induced peripheral neuropathy (CIPN) — a common side effect of drugs like paclitaxel, vincristine, and platinum-based agents
• Idiopathic neuropathy — no identifiable cause, frustratingly common
• Autoimmune neuropathy — associated with conditions like lupus, Sjögren's syndrome, and CIDP
• Post-herpetic neuralgia — nerve pain following shingles

What these conditions share, beyond the peripheral nerve damage, is something more insidious: central sensitization. Over time, repeated pain signals rewire the central nervous system itself, amplifying pain responses and making the brain hypersensitive to stimuli that should be neutral.

This is exactly where ketamine's mechanism becomes compelling.

How Ketamine Interrupts Neuropathic Pain

Standard neuropathy treatments — gabapentin (Neurontin), pregabalin (Lyrica), duloxetine (Cymbalta), and tricyclic antidepressants — work primarily on peripheral nerve activity or serotonin/norepinephrine reuptake. They dampen signals at the edges.

Ketamine works differently. As an NMDA (N-methyl-D-aspartate) receptor antagonist, it blocks the central glutamate receptors responsible for wind-up — the neurological process by which repeated pain signals amplify over time. By blocking these receptors, ketamine can interrupt the central sensitization cycle that has become self-perpetuating.

In practical terms, this means ketamine can provide relief that isn't just peripheral signal dampening — it's a reset of the central nervous system's pain amplification machinery.

What Does the Research Show?

The evidence for ketamine in neuropathic pain has been building for over two decades:

• A 2018 systematic review in Pain Medicine found that IV ketamine infusions produced significant short-term reductions in neuropathic pain across multiple studies, with benefits lasting weeks to months.
• Studies specifically on diabetic neuropathy have shown ketamine can reduce pain scores by 40-60% in responsive patients — outperforming gabapentin in some head-to-head comparisons.
• For CIPN, a condition notoriously resistant to treatment, small trials have shown meaningful relief with ketamine where other interventions have failed.
• The mechanism is now understood well enough that ketamine is included in several international pain management guidelines as a second- or third-line option for refractory neuropathic pain.

It's important to be honest: not every neuropathy patient responds to ketamine. Response rates vary by condition, severity, and duration of neuropathy. Patients with long-standing neuropathy and significant central sensitization often respond better than those with primarily peripheral nerve damage alone.

Who Qualifies for Ketamine Neuropathy Treatment?

Ketamine for neuropathic pain is most appropriate for patients who:

• Have tried and failed at least two first-line neuropathy medications (gabapentin, pregabalin, duloxetine, or tricyclics)
• Have a confirmed neuropathy diagnosis
• Don't have contraindications to ketamine (uncontrolled hypertension, active psychosis, certain cardiac conditions)
• Are not currently in active substance abuse

Many neuropathy patients also have comorbid depression or anxiety — not surprising given the relentlessness of chronic pain. Ketamine uniquely addresses both simultaneously, which is a significant advantage over pain-specific medications.

If neuropathy has been affecting your sleep and mental health alongside the physical pain, also read about ketamine for chronic fatigue and its mental health applications and how ketamine works for treatment-resistant depression.

Realistic Expectations

We want to be clear about what ketamine can and cannot do for peripheral neuropathy:

What it can do:

• Reduce pain intensity, often significantly (40-70% reduction in responsive patients)
• Improve sleep disrupted by pain
• Address comorbid depression and anxiety
• Restore quality of life and functional capacity

What it won't do:

• Reverse the underlying nerve damage (nothing does, currently)
• Eliminate pain permanently in most patients — maintenance sessions are often needed
• Work for everyone — roughly 30-40% of patients are non-responders

For patients who do respond, the results can be life-changing. Patients who haven't slept through the night in years. Patients who've stopped exercising because of foot pain. Patients who've been told "just learn to live with it" — who suddenly have a different option.

Treatment Protocol for Neuropathy

For chronic neuropathic pain, treatment typically involves an initial series of 4-6 ketamine sessions over 2-3 weeks, followed by maintenance sessions as needed. The interval between maintenance sessions varies — some patients find monthly sessions sufficient; others manage with quarterly.

At Discreet Ketamine, all sessions are done at home with sublingual ketamine prescribed and monitored by a board-certified physician. The at-home format is particularly valuable for neuropathy patients who may have limited mobility or find travel difficult.

For patients using other medications alongside ketamine, it's important to review compatibility. See our guide to medications safe to take with ketamine for details.

The Path Forward

For too long, peripheral neuropathy patients have been offered a rotating door of medications that provide modest, partial relief — or none at all. Ketamine represents a mechanistically distinct approach that targets the central pain amplification processes standard drugs can't reach.

If you've been living with nerve pain and standard treatments haven't given you the relief you need, ketamine may be worth a serious conversation.

Take our free eligibility quiz to find out if you're a candidate for at-home ketamine treatment. Our physician team will review your history and respond within 24 hours. You can also browse our full library of pain and treatment resources to learn more.